DORIS VAN BYSSUM: Open Payments
NPI 1063515369 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,821 in 24 payments from 11 companies in 2025. Trend: 2023 $8,404 · 2024 $5,614 · 2025 $5,821
Speaker / faculty: $4,366Travel & lodging: $859Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $5,559 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, COBENFY, VRAYLAR, Sunosi, FANAPT, ABILIFY MAINTENA, ARISTADA, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
